TIER 1 TIER 1
TIER 2 TIER 2
TIER 1 TIER 1
BAND 2 BAND 2

Our Practice

EBN’s Hi-Tech department is outstanding in the Israeli technology landscape and recognized for its leadership in the sector. We provide strategic counsel to a diverse clientele, including emerging technology ventures, established enterprises, and notable investors.

We advise clients through every phase of their lifecycle and provide comprehensive assistance from pre inception, to inception, to growth and beyond. Our services encompass fundraising, commercial endeavors, intellectual property protection, and diverse ongoing commercial agreements, including licensing, technology, development, manufacturing, OEM, and joint ventures.

Additionally, we serve as trusted advisors to numerous Israeli and international investors, such as private equity and venture capital funds, corporate ventures, angel investors, and strategic partners.

Our end-to-end services span various industries, including cybersecurity, AI, defense-tech, automotive, IT, FinTech, IoT, big data, semiconductors, software, Internet, life sciences and more.

We frequently act as local counsel for renowned international law firms representing global clients in acquisitions and investment transactions within the Israeli Hi-Tech and start-up ecosystem.

Our clients benefit from the comprehensive support of a dedicated team that seamlessly collaborates with EBN’s other well-resourced departments and practices that include tax, labor, privacy, IP, real estate and other. Leveraging the firm’s diverse expertise, we ensure our clients have access to pertinent legal guidance across multiple domains, enriching their strategic decision-making and fostering their growth and success.

Recent Highlights

Representative Experience

Representing technology companies in their fundraising:

  • Urogen Pharma: $120M pipe transaction
  • Guesty: $130M Series F Financing
  • Fortellix: $85M Series C Financing
  • DataGen: $50M Series C Financing
  • Bluewhite: $39 Series C Financing
  • Supplant: $38M Series C Financing
  • RecoLabs: $30M Series A Financing
  • Anecdotes: $25M Series B Financing
  • Arbe Robotics: $23M private placement
  • HyperGuest: $23M Series A Financing
  • DigitalOwl: $20M Series A Financing
  • Mediterranean Food Lab: $17M Series A Financing
  • PhaseV: $15M Series Seed Financing

Representation in Acquisitions by our technology company clients:

  • Guesty: Acquisition of Kigo, HiRUM, and MyVR
  • Bizzabo: Acquisitions of Klik, Whalebone, x.ai, and Teevid assets

Representation in M&A Transactions

  • Permira in the acquisition of control in BioCatch at a company valuation of USD 1.305 billion
  • Vertex Ventures in the sale of its holdings in Adaptive Shield to CrowdStrike at a company valuation of $300 million.
  • Emerge Ventures, Insight Partners and Square Peg in the sale of their holdings in Deci AI to Nvidia
  • 365 scores in its aquation by Entain for $150M
  • Moovex.ai in its sale to iCabbi
  • TEOCCO in the sale of its service assurance division to Amdocs
  • Arbe Robotics (NASDAQ) in its de-SPAC transaction with Industrial Tech Acquisitions
  • Hellman & Friedman in the purchase of Checkmarx for USD 1.15 billion.
  • Amiti Ventures, Amdocs Ventures and Singtel Innov8 in the sale of their holdings in Flow Security to CrowdStrike
  • Walmart on various acquisitions, including of Zeekit and Aspectiva.
  • Byond Trust (a Francisco Partners portfolio company) on its acquisition of Entitle

Venture Capital and Institutional Investors Representation

Vertex Ventures, Amiti Ventures, Hetz Ventures, Emerge, TLV Partners, Red Dot Capital Partners, F2, S2G, Mor, Greycroft, Maor Investments and IBI Tech.

Strategic Investors Representation

Motorola, Walmart, Hitachi Ventures, STMicroelectronics, UMC Capital, Tyson Ventures, Trumpf Ventures and many other.

Legal Updates & Cases